Lukas Martin Selected Research

Lukas Martin Research Topics

Disease

22	Sepsis (Septicemia) 01/2023 - 01/2013
13	Inflammation (Inflammations) 01/2024 - 01/2013
8	Septic Shock (Toxic Shock Syndrome) 12/2020 - 01/2015
7	Wounds and Injuries (Trauma) 01/2023 - 01/2017
6	Critical Illness (Critically Ill) 09/2022 - 01/2015
5	Acute Kidney Injury (Acute Renal Failure) 02/2021 - 01/2018
5	Cardiomyopathies (Cardiomyopathy) 01/2020 - 12/2015
4	COVID-19 08/2023 - 02/2021
4	Myocardial Infarction 01/2022 - 01/2018
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2021 - 12/2018
3	Thoracoabdominal Aortic Aneurysm 10/2020 - 01/2017
2	Disease Progression 09/2022 - 01/2017
2	Shock 01/2022 - 12/2020
2	Multiple Trauma (Multiple Injuries) 01/2022 - 10/2019
2	Hypoxia (Hypoxemia) 01/2022 - 01/2017
2	Ischemia 01/2022 - 11/2017
2	Hypotension (Low Blood Pressure) 01/2022 - 12/2020
2	Infections 11/2021 - 08/2016
2	Abdominal Aortic Aneurysm 02/2021 - 01/2019
2	Lung Injury 10/2019 - 01/2018
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 01/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2016 - 12/2015
1	Carcinogenesis 01/2024
1	Dysbiosis 01/2024
1	Virus Diseases (Viral Diseases) 08/2023
1	Pulmonary Embolism 04/2023
1	Hemorrhage 04/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Multiple Organ Failure (MODS) 01/2022
1	Fatty Liver 01/2021
1	Hypercholesterolemia 01/2021
1	Insulin Resistance 01/2021
1	Fabry Disease (Fabry's Disease) 01/2021
1	Obesity 01/2021
1	Proteinuria 01/2021
1	Pneumonia (Pneumonitis) 01/2020
1	Cicatrix (Scar) 11/2019
1	Heart Failure 11/2019
1	Atrophy 10/2019
1	Contusions 10/2019
1	Hemorrhagic Shock 10/2019

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2017
7	Peptides (Polypeptides)IBA 08/2023 - 01/2013
6	Heparitin Sulfate (Heparan Sulfate)IBA 09/2022 - 01/2015
6	Antimicrobial PeptidesIBA 11/2016 - 01/2013
5	CytokinesIBA 01/2022 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2018
4	Ribonucleases (Ribonuclease)IBA 08/2023 - 02/2016
4	heparanaseIBA 09/2022 - 01/2015
4	Pep19-2.5 peptideIBA 01/2021 - 01/2013
4	LipopolysaccharidesIBA 01/2017 - 01/2013
3	Macrophage Migration-Inhibitory FactorsIBA 01/2022 - 11/2017
3	AdrenomedullinIBA 04/2021 - 01/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2015
2	InflammasomesIBA 01/2021 - 01/2019
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2015 - 01/2015
1	ProteomeIBA 01/2024
1	Antiviral Agents (Antivirals)IBA 08/2023
1	Conditioned Culture MediaIBA 12/2022
1	Caspase 3 (Caspase-3)IBA 12/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Carbon MonoxideIBA 01/2022
1	ImidocarbIBA 11/2021
1	Tissue Inhibitor of Metalloproteinase-2IBA 02/2021
1	migalastatIBA 01/2021
1	agalsidase beta FDA Link 01/2021
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2021
1	Adenosine Monophosphate (AMP)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	agalsidase alfaIBA 01/2021
1	enibarcimabIBA 12/2020
1	SolutionsIBA 12/2020
1	omega-Chloroacetophenone (Mace)IBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA 01/2020
1	CollagenIBA 11/2019
1	Fibrillar CollagensIBA 11/2019
1	Collagen Type V (Type V Collagen)IBA 11/2019
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2019
1	ibrutinibIBA 01/2019
1	acalabrutinibIBA 01/2019
1	Lipocalin-2IBA 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	artenimol (dihydroartemisinin)IBA 01/2018

Therapy/Procedure

12	Therapeutics 04/2023 - 01/2015
4	Resuscitation 01/2022 - 01/2019
2	Renal Replacement Therapy (Therapies, Renal Replacement) 04/2021 - 02/2021
2	Artificial Respiration (Mechanical Ventilation) 02/2021 - 10/2019
2	Punctures 01/2020 - 01/2013
2	Ligation 01/2020 - 01/2013
1	Catheters 04/2023
1	Embolectomy 04/2023
1	Precision Medicine 01/2022
1	Extracorporeal Membrane Oxygenation 04/2021
1	Enzyme Replacement Therapy 01/2021
1	Laparotomy 10/2019
1	Mechanical Ventilators (Ventilator) 10/2019
1	Intravenous Administration 01/2019
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2018